Safety Study of LLF580 in Obese Volunteers

NCT03466203 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

BIOLOGICAL: LLF580
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals